Thursday, March 31, 2016
Monday, March 28, 2016
Monday, March 14, 2016
MERZ ANNOUNCES NATIONWIDE AVAILABILITY OF NEW 200-UNIT VIAL OF XEOMIN®
Merz North America (U.S. affiliate of the global Merz Pharma Group), today announced the nationwide availability of Xeomin® (incobotulinumtoxinA) in a 200-unit single-dose vial. This new dosage size supports the dosing associated with the recently approved adult upper limb spasticity indication for Xeomin® (incobotulinumtoxinA). Xeomin® (incobotulinumtoxinA) is now available to healthcare providers in the US in three single-dose vial sizes: 50 unit, 100 unit and 200 unit, with the same price per toxin unit for all three sizes. Each vial size has a different color label, stopper and top to promote ease of use.
Read more:
Thursday, March 10, 2016
Wednesday, March 9, 2016
Friday, March 4, 2016
Subscribe to:
Posts (Atom)